Related Experiment Video
Updated: May 15, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Reciprocal regulation of cholesterol excretion in apolipoprotein E-null mice by angiotensin II type 1 and type 2
Masaru Iwai1, Hisako Sone, Harumi Kanno
1Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Tohon, Ehime, Japan.
Aims:
The effects of AT(1) and AT(2) receptor deficiency on the intake and excretion of cholesterol were examined using atherosclerotic apolipoprotein E-null (ApoEKO) mice.
Main Methods:
ApoEKO, AT(1)a/ApoEKO and AT(2)/ApoEKO mice received a high-cholesterol diet (HCD: 1.25% cholesterol) for 10 days before sampling.
Key Findings:
Plasma total cholesterol level was lower in AT(1)a/ApoEKO mice and higher in AT(2)/ApoEKO mice than in ApoEKO mice with a high cholesterol intake. In these mice, cholesterol content in feces was higher in AT(1)a/ApoEKO mice and lower in AT(2)/ApoEKO mice than in ApoEKO mice. Moreover, cholesterol content in bile tended to be higher in AT(1)a/ApoEKO mice and lower in AT(2)/ApoEKO mice than in ApoEKO mice, while a significant difference was observed only between AT(1)a/ApoEKO and AT(2)/ApoEKO mice. Cholesterol content and expression of HMG-CoA reductase and LDL receptor in liver were not different among the groups. Similar but weaker changes were also observed with a normal standard diet. Treatment with an AT(1) receptor blocker, irbesartan, increased cholesterol content in bile and tended to increase cholesterol excretion into feces in ApoEKO mice with HCD.
Significance:
These results suggest that AT(1) and AT(2) receptor stimulation was involved in the regulation of cholesterol excretion into bile and feces, and that the regulation acted reciprocally in a cholesterol overload condition with HCD.
Insights
Angiotensin (AT) receptor deficiency impacts cholesterol excretion. AT(1) receptor deficiency increases fecal cholesterol, while AT(2) receptor deficiency decreases it, suggesting reciprocal regulation in high-cholesterol conditions.
Area of Science:
- Cardiovascular Research
- Metabolic Regulation
- Pharmacology
Background:
- Atherosclerosis is a complex disease involving lipid metabolism.
- The renin-angiotensin system, including AT(1) and AT(2) receptors, plays a role in cardiovascular function.
- Understanding the role of these receptors in cholesterol homeostasis is crucial for managing atherosclerosis.
Purpose of the Study:
- To investigate the effects of AT(1) and AT(2) receptor deficiency on cholesterol intake and excretion.
- To elucidate the reciprocal roles of AT(1) and AT(2) receptors in cholesterol metabolism during high-cholesterol diet conditions.
Main Methods:
- Utilized apolipoprotein E-null (ApoEKO) mice, a model for atherosclerosis.
- Generated AT(1)a/ApoEKO and AT(2)/ApoEKO mice to study receptor deficiency.
- Administered a high-cholesterol diet (HCD) and analyzed plasma, fecal, and bile cholesterol levels.
- Examined liver cholesterol content and gene expression of HMG-CoA reductase and LDL receptor.
- Investigated the effect of an AT(1) receptor blocker (irbesartan) on cholesterol excretion in ApoEKO mice.
Main Results:
- AT(1)a/ApoEKO mice showed lower plasma cholesterol and higher fecal/bile cholesterol compared to ApoEKO mice.
- AT(2)/ApoEKO mice exhibited higher plasma cholesterol and lower fecal/bile cholesterol.
- Liver cholesterol content and key enzyme expression remained unchanged among groups.
- Irbesartan treatment increased bile cholesterol and tended to increase fecal cholesterol excretion in ApoEKO mice on HCD.
Conclusions:
- AT(1) and AT(2) receptor stimulation reciprocally regulate cholesterol excretion into bile and feces.
- These receptors play a significant role in cholesterol homeostasis, particularly under conditions of cholesterol overload.
- Targeting AT(1) receptors may offer a therapeutic strategy for enhancing cholesterol excretion in atherosclerosis.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Cholesterol: Significance and Regulation
Considering cholesterol and...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation

